Samuel R. Nussbaum MD

Filings by Samuel R. Nussbaum MD span 3 companies, the busiest being Elevance Health, Inc., Motus GI Holdings, Inc. and Biora Therapeutics, Inc. Between 1 March 2006 and 14 June 2021, the trades on record add up to 88 filings.

Both buying and selling appear: 1 purchase worth €40k, against 26 sales worth €42.8M. Sales outweigh purchases by €42.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 44 share grants and 17 option exercises.

The record was last updated on 16 June 2021 with a share grant in Biora Therapeutics, Inc. The last purchase on record was published on 21 February 2018, which is 3,167 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.